CORTICOTROPIN-RELEASING HORMONE PRODUCTION BY A SMALL-CELL CARCINOMA IN A PATIENT WITH ACM-DEPENDENT CUSHINGS-SYNDROME

被引:17
作者
AUCHUS, RJ
MASTORAKOS, G
FRIEDMAN, TC
CHROUSOS, GP
机构
[1] UNIV TEXAS,HLTH SCI CTR,DIV ENDOCRINOL,SAN ANTONIO,TX
[2] NICHHD,DEV ENDOCRINOL BRANCH,BETHESDA,MD
[3] NICHHD,DEV NEUROBIOL LAB,BETHESDA,MD
关键词
CORTICOTROPIN-RELEASING HORMONE; ECTOPIC HORMONES; CUSHINGS SYNDROME; SMALL-CELL LUNG CANCER; HYPERCORTISOLEMIA; IMMUNOCYTOCHEMISTRY; ADRENOCORTICOTROPIC HORMONE;
D O I
10.1007/BF03347737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a patient with Cushing's syndrome and metastatic small cell lung cancer. The plasma ACTH concentrations were markedly elevated (91.6 pmol/L), and the AM cortisol did not suppress by >50% overnight after administration of 8 mg dexamethasone, both consistent with the ectopic ACTH syndrome. Immunohistochemical studies of a single metastatic tumor specimen, however, demonstrated an absence of ACTH and yet an abundance of corticotropin-releasing hormone (CRH). In addition, radioimmunoassay of the patient's plasma demonstrated persistently elevated CRH concentrations. The majority of the plasma CRH immunoreactivity exhibited the same chromatographic mobility as synthetic r/h CRH (1-41) on HPLC. Failure to evaluate the tumor tissue for the presence of ACTH and/or CRH would have led to the erroneous conclusion that this patient's Cushing's syndrome resulted from paraneoplastic ACTH production. We conclude that immunoassay of plasma for both ACTH and CRH and, perhaps, immunostaining of tumor samples are required to distinguish between the ectopic ACTH and CRH syndromes.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 28 条
  • [1] ASA SL, 1984, ANN INTERN MED, V101, P789, DOI 10.7326/0003-4819-101-6-789
  • [2] SERUM CORTISOL-LEVELS IN CUSHINGS-SYNDROME AFTER LOW-DOSE AND HIGH-DOSE DEXAMETHASONE SUPPRESSION
    ASHCRAFT, MW
    VANHERLE, AJ
    VENER, SL
    GEFFNER, DL
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) : 21 - 26
  • [3] CUSHINGS-SYNDROME DUE TO ECTOPIC PRODUCTION OF CORTICOTROPIN-RELEASING FACTOR
    BELSKY, JL
    CUELLO, B
    SWANSON, LW
    SIMMONS, DM
    JARRETT, RM
    BRAZA, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (03) : 496 - 500
  • [4] CONTINUOUS DEXAMETHASONE INFUSION FOR 7 HOURS IN PATIENTS WITH THE CUSHING SYNDROME - A SUPERIOR DIFFERENTIAL DIAGNOSTIC-TEST
    BIEMOND, P
    DEJONG, FH
    LAMBERTS, SWJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) : 738 - 742
  • [5] NOCTURNAL HIGH-DOSE DEXAMETHASONE SUPPRESSION TEST IN THE ETIOLOGICAL DIAGNOSIS OF CUSHINGS-SYNDROME
    BRUNO, OD
    ROSSI, MA
    CONTRERAS, LN
    GOMEZ, RM
    GALPARSORO, G
    CAZADO, E
    KRAL, M
    LEBER, B
    ARIAS, D
    [J]. ACTA ENDOCRINOLOGICA, 1985, 109 (02): : 158 - 162
  • [6] EFFECTS OF SEROTONERGIC AGONISTS AND ANTAGONISTS ON CORTICOTROPIN-RELEASING HORMONE-SECRETION BY EXPLANTED RAT HYPOTHALAMI
    CALOGERO, AE
    BERNARDINI, R
    MARGIORIS, AN
    BAGDY, G
    GALLUCCI, WT
    MUNSON, PJ
    TAMARKIN, L
    TOMAI, TP
    BRADY, L
    GOLD, PW
    CHROUSOS, GP
    [J]. PEPTIDES, 1989, 10 (01) : 189 - 200
  • [7] ECTOPIC SECRETION OF CORTICOTROPIN-RELEASING FACTOR AS A CAUSE OF CUSHINGS-SYNDROME - A CLINICAL, MORPHOLOGIC, AND BIOCHEMICAL-STUDY
    CAREY, RM
    VARMA, SK
    DRAKE, CR
    THORNER, MO
    KOVACS, K
    RIVIER, J
    VALE, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (01) : 13 - 20
  • [8] DIAGNOSTIC EVALUATION OF CUSHINGS-SYNDROME
    CARPENTER, PC
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1988, 17 (03) : 445 - 472
  • [9] CHARACTERIZATION OF HUMAN CORTICOTROPHIN-RELEASING HORMONE AND PRO-OPIOMELANOCORTIN-RELATED PEPTIDES IN A THYMIC CARCINOID-TUMOR RESPONSIBLE FOR CUSHINGS-SYNDROME
    DEMAY, MCR
    PROESCHEL, MF
    DEKEYZER, Y
    BERTAGNA, X
    LUTON, JP
    GIRARD, F
    [J]. CLINICAL ENDOCRINOLOGY, 1988, 29 (06) : 649 - 657
  • [10] DLUHY RG, 1987, NEW ENGL J MED, V317, P1648